GREY:TSTIF - Post by User
Post by
Blue_Skyon Aug 21, 2018 3:21pm
261 Views
Post# 28494920
TSO3 1 Year Return
TSO3 1 Year ReturnTSO3 is the 5th worst performing healthcare stock on the Canadian market over the last 12 months. What are we getting for $371,231 base salary, $530,830 option based awards, $243,620 annual incentive plan and $11,860 Pension contribution for a total of $1,181,541 in comp??? If you had invested $1.0 M in TSO3 1 year ago while Rumble was selling your investment would have cost you $730,000. Rumble made $1.2 M for contributing to 73% loss to your investment for the past 1 year!!
1. Neovasc Inc. -95.19%
2. Concordia International -84.42%
3. Evitrade Health Systems -73.33%
4. Preveceutical Medical Inc. -72.97
5. TSO3 -73.18%
Cash and everyone else that fails to recognize the point I am trying to hammer home; the performance at this company has been so terrible that we are the 5th worst performing HC stock in the market yet all I hear about is how unique and special our product is. If you truely believe that (as I do) then there is a terrible problem with execution. I ask again, why are we giving Rumble and his team another shot at this? If you failed this miserably at your job would you still be employed? If you were a baseball player that struck out every time you appearded at the plate would you still be in the majors? Rumble has failed at every turn. Reach out to the board and voice your disastisfaction. I fear the results if he fails yet again.